The association between COVID-19 and cardiovascular diseases

DOI IR Open Access
  • Funamoto Masafumi
    Department of Pharmacology, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima, Japan
  • Ikeda Yasumasa
    Department of Pharmacology, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima, Japan

Bibliographic Information

Other Title
  • COVID-19と循環器疾患との関連について

Search this article

Description

<p>Coronavirus disease-2019 （COVID-19） induces of multi-organs damage including heart, vessels, and lung neurological systems in addition to respiratory disorders, causing subsequent complications.　Patients with cardiovascular damage induced by COVID-19 show ischemic heart disease, arrhythmias, and venous thromboembolism, resulting in death.　Patients with a medical history of hypertension, diabetes, and coronary artery disease are associated with an increased rate of aggravation and mortality.　It is very important to prevent the onset of cardiovascular complications caused by COVID-19, however, there are no therapeutics for them and new treatments and therapeutic agents need to be developed.　Kampo medicine is a traditional Japanese herbal medicine and has been attracting attention in the treatment of COVID-19.　This article outlines the pathophysiological findings of COVID-19-related cardiovascular complications and the potential effect of Kampo as supportive care against it.</p>

Journal

Related Projects

See more

Keywords

Details 詳細情報について

Report a problem

Back to top